FUJIFILM Invests $200 Million to Expand iPSC Manufacturing Capacity in Madison

Specifications:

Name:

FUJIFILM Invests $200 Million to Expand iPSC Manufacturing Capacity in Madison

Location:

USA

Company:

FUJIFILM

Estimated Cost:

$200 Million

Source:

fujifilm.com

Introduction

FUJIFILM Cellular Dynamics Inc. has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development and manufacturing facility in Madison, Wisconsin. The new site forms part of Fujifilm’s previously announced $200 million investment programme and is designed to support rising demand for stem cell-based research products, development services, and future cell therapy manufacturing.

Key Features

The 175,000-square-foot facility will increase the company’s manufacturing capacity for iPSC-based research products and services by fourfold.

The site features advanced cell culture manufacturing laboratories, process development laboratories, and a dedicated gene-editing centre of excellence to support the production of research-grade iPSC products and the development of next-generation cell therapies.

Designed for long-term growth, the facility can scale operations from investigational drug manufacturing to large-scale commercial production of cell therapy products as market demand increases.

The expanded infrastructure will also enhance manufacturing of the company’s iPSC-derived iCell product portfolio, which is widely used in drug discovery and safety assessment.